Table 1. Summary of sequences analysis.
| Sample | Raw Reads | Clean Reads | Clean Bases | Error (%) | Q20 (%) | Q30 (%) | GC (%) |
|---|---|---|---|---|---|---|---|
| CT1_1 | 24750909 | 23407132 | 2.93G | 0.03 | 96.91 | 93.54 | 55.05 |
| CT1_2 | 24750909 | 23407132 | 2.93G | 0.04 | 93.22 | 87.58 | 54.98 |
| CT2_1 | 21572245 | 20537549 | 2.57G | 0.03 | 97.04 | 93.82 | 54.76 |
| CT2_2 | 21572245 | 20537549 | 2.57G | 0.04 | 92.54 | 86.61 | 54.67 |
| CK1_1 | 23683593 | 22616430 | 2.83G | 0.03 | 96.97 | 93.60 | 55.64 |
| CK1_2 | 23683593 | 22616430 | 2.83G | 0.04 | 93.22 | 87.57 | 55.53 |
| CK2_1 | 23164623 | 21997516 | 2.75G | 0.03 | 96.87 | 93.40 | 55.77 |
| CK2_2 | 23164623 | 21997516 | 2.75G | 0.05 | 92.41 | 86.21 | 55.66 |
| Total | 186342740 | 177117254 | 22.16G |
CT1, CT2: Controlled medullar tissue.
CK1, CK2: Treated medullar tissue.
Q20: The percentage of bases with a Phred value > 20.
Q30: The percentage of bases with a Phred value > 30.